Varicella zoster virus the ACIP recommended a second dose of vaccine before school entry to ensure the maintenance of high levels of varicella immunity. In 2006, the United States Food and Drug Administration approved Zostavax for the prevention of shingles. Zostavax is a more concentrated formulation of the Varivax vaccine, designed to elicit an immune response in older adults whose immunity to VZV wanes with advancing age. A systematic review by the Cochrane Library shows that Zostavax reduces the incidence of shingles by almost 50%. Shingrix is a "V. zoster" vaccine developed by GlaxoSmithKline which was approved in the United States by the
Brazilian disease Brazilian disease Brazilian disease is a phrase in economics to describe the situation in which the Brazilian real has strengthened (trading at around R$1.95 to the US dollar) on high prices for commodities such as soybeans, making Brazilian exports of manufactured goods uncompetitive in foreign markets. The term was coined to compare the economic situation facing Brazilian exports in the late 2000s to Dutch disease, an older term referring to similar conditions faced in the Netherlands in the 1960s and 1970s due to massive natural gas exports. The term "Brazilian disease" has not been widely used in economic literature or